Tailored Cancer Vaccines? NousCom is working on it!

30/09/2016 - 1 minute

We aren’t leaving Switzerland yet! We took a scenic train to Basel in order to meet nousCom, a very young biotech developing cancer vaccines.

nouscom logoCity: Basel, Switzerland

Founded: 2015

Employees: unknown

Financial Data: €12M raised in series A

Mission: NousCom is a Biotech that develops next generation cancer vaccines with patient- and tumor-specific antigens. Their vaccines combine viruses modified to selectively target tumor antigens and adenoviral vectors for the delivery of cancer antigens.

Comment: The company is getting ready to compete against the big players in immuno-oncology with an expert team, big investors, brand-new GMP labs and innovative science. We expect hearing about positive results very soon. And we like the strong presence of women in their Senior Management Board!

Feature Image Credit: Labiotech Map

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!